A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools

被引:131
作者
Freeston, J. E. [1 ]
Wakefield, R. J. [1 ]
Conaghan, P. G. [1 ]
Hensor, E. M. A. [1 ]
Stewart, S. P. [1 ]
Emery, P. [1 ]
机构
[1] Univ Leeds, Chapel Allerton Hosp, Acad Sect Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England
关键词
RHEUMATOID-ARTHRITIS; ULTRASONOGRAPHY;
D O I
10.1136/ard.2008.106658
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objectives: The aim of this study was to assess the value of power Doppler ultrasound (PDUS) in combination with routine management in a cohort of patients with very early inflammatory arthritis (IA). Methods: 50 patients with <= 12 weeks of inflammatory symptoms with or without signs had clinical, laboratory and imaging assessments. Diagnosis was recorded at 12 months. Assuming a 15% pre-test probability of IA, post-test probabilities for various assessments were calculated and used to develop a diagnostic algorithm. Results: All patients positive for rheumatoid factor (RF) and/or cyclic citrullinated peptide (CCP) developed persistent IA, so the added value of PDUS was assessed in the seronegative (RF and CCP negative) group. The probability of IA in a seronegative patient was 6%. The addition of clinical and radiographic features raised the probability of IA to 30% and, with certain ultrasound features, this rose to 94%. Conclusions: In seronegative patients with early IA, combining PDUS with routine assessment can have a major impact on the certainty of diagnosis.
引用
收藏
页码:417 / 419
页数:3
相关论文
共 17 条
[1]
ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
[2]
Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression [J].
Brown, A. K. ;
Quinn, M. A. ;
Karim, Z. ;
Conaghan, P. G. ;
Peterfy, C. G. ;
Hensor, E. ;
Wakefield, R. J. ;
O'Connor, P. J. ;
Emery, P. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3761-3773
[3]
Green M, 1999, ARTHRITIS RHEUM, V42, P2184, DOI 10.1002/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO
[4]
2-2
[5]
Karim Z, 2001, ARTHRITIS RHEUM, V44, P2932, DOI 10.1002/1529-0131(200112)44:12<2932::AID-ART481>3.0.CO
[6]
2-3
[7]
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: Comparison of two cohorts who received different treatment strategies [J].
Lard, LR ;
Visser, H ;
Speyer, I ;
vander Horst-Bruinsma, IE ;
Zwinderman, AH ;
Breedveld, FC ;
Hazes, JMW .
AMERICAN JOURNAL OF MEDICINE, 2001, 111 (06) :446-451
[8]
Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis [J].
Nell, VPK ;
Machold, KP ;
Eberl, G ;
Stamm, TA ;
Uffmann, M ;
Smolen, JS .
RHEUMATOLOGY, 2004, 43 (07) :906-914
[9]
Raza K, 2005, J RHEUMATOL, V32, P231
[10]
How to diagnose axial spondyloarthritis early [J].
Rudwaleit, M ;
van der Heijde, D ;
Khan, MA ;
Braun, J ;
Sieper, J .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) :535-543